American Express
AXP
$312.24
-0.40%
American Express Company is a global financial institution operating in the Financial - Credit Services industry, providing charge and credit card payment products, a merchant payment network, and commercial services like expense management tools and business loans. The company is a premier, closed-loop network operator and a market leader in the premium and corporate card segments, distinguished by its direct relationships with both cardholders and merchants. The current investor narrative revolves around its resilience in a potentially slowing economic environment, its ability to maintain robust growth among affluent consumers, and the emerging competitive threat from fintech players like Robinhood entering the premium card space, as highlighted in recent news.…
AXP
American Express
$312.24
Related headlines
Investment Opinion: Should I buy AXP Today?
Rating & Thesis: Hold. AXP is a fundamentally strong company caught in a negative momentum cycle, making it premature to buy the dip but also too early to sell given its attractive forward valuation and cash generation. The mixed analyst sentiment (with recent Buy, Sell, and Hold ratings) reflects this uncertainty and lack of a clear near-term catalyst.
Supporting Evidence: The primary valuation support is the forward P/E of 15.58x, which is a 34% discount to the trailing multiple and suggests the market has already priced in significant headwinds. The company continues to grow revenue (9.5% YoY in Q4) and maintains exceptional profitability metrics, including an 83.49% gross margin and a 32.36% ROE. Furthermore, its massive $16.0 billion TTM free cash flow provides a solid foundation for capital returns. However, these strengths are counterbalanced by the clear downtrend, decelerating growth, and premium trailing multiples.
Risks & Conditions: The two biggest risks are a continuation of the revenue and earnings deceleration into 2026, and a failure to stabilize the stock's technical breakdown. This Hold rating would upgrade to a Buy if the stock finds firm support above its 52-week low and shows a sustained reversal in momentum, or if forward earnings estimates are revised meaningfully higher. It would downgrade to a Sell if Q4's sequential net income decline becomes a trend and the stock breaches the $281 support level. On valuation, the stock appears fairly valued to slightly overvalued on a trailing basis but offers value on a forward-looking basis if its growth stabilizes.
Sign up to view all
AXP 12-Month Price Forecast
The AI assessment is neutral with medium confidence. AXP's superb fundamentals are at odds with its terrible price action. The forward valuation is compelling, but only if the company can arrest the deceleration in its top and bottom-line growth. The stock likely needs time to base and for investors to gain confidence that the growth story is not broken. The stance would upgrade to bullish on evidence of sequential earnings improvement and a sustained technical reversal above the $340-$350 resistance zone. It would turn bearish if the stock breaks $281 support, signaling the fundamental deterioration is worse than feared.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on American Express's 12-month outlook, with a consensus price target around $405.91 and implied upside of +30.0% versus the current price.
Average Target
$405.91
5 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
5
covering this stock
Price Range
$250 - $406
Analyst target range
Analyst coverage for AXP appears limited, with only 5 analysts providing estimates for revenue and EPS, suggesting it may have less institutional coverage than mega-cap peers. The consensus sentiment, based on the sparse institutional ratings data, is mixed with recent actions including a 'Buy' from Truist Securities, a 'Sell' from BTIG, and 'Neutral' or 'Hold' ratings from JP Morgan, TD Cowen, and Barclays, indicating a lack of strong directional conviction. The average EPS estimate for the coming period is $28.25, with a range from $27.10 to $28.63, implying a relatively tight spread of about 5.4%, which suggests higher conviction in the near-term earnings outlook despite the mixed recommendations. The implications of limited coverage include potentially higher volatility and less efficient price discovery, as the stock may be more influenced by macroeconomic factors and broad financial sector trends than by nuanced fundamental analysis from a large analyst community.
Bulls vs Bears: AXP Investment Factors
The evidence currently tilts bearish, driven by a severe technical breakdown and clear signs of fundamental deceleration in both revenue and earnings. The bull case rests on AXP's still-strong profitability, discounted forward valuation, and robust cash generation, but these strengths are being overshadowed by negative price momentum and growth concerns. The single most important tension in the investment debate is whether the significant discount in the forward P/E (15.58x) correctly anticipates an earnings reacceleration, or if it is merely a trailing indicator of a deteriorating growth profile that will lead to further multiple compression. The resolution of this growth trajectory in the coming quarters will be the primary determinant of the stock's direction.
Bullish
- Strong Profitability & High ROE: The company maintains robust profitability with a gross margin of 83.49% and a net margin of 13.46% for Q4 2025. Its return on equity of 32.36% is exceptionally high, indicating superior efficiency in generating profits from shareholder equity.
- Significant Forward P/E Discount: The forward P/E of 15.58x represents a 34% discount to the trailing P/E of 23.73x, signaling the market expects a substantial earnings rebound. This forward multiple suggests the stock is priced for attractive earnings growth over the next year.
- Ample Liquidity & Strong Cash Flow: AXP generates substantial free cash flow, with a TTM figure of $16.0 billion. This provides significant financial flexibility to fund shareholder returns through dividends (0.88% yield) and buybacks, and to invest in growth initiatives.
- Resilient Revenue Growth: Despite sequential deceleration, Q4 2025 revenue grew 9.5% year-over-year to $21.04 billion. The Global Consumer Services segment, at $9.16 billion, remains a solid core growth driver, demonstrating resilience in the premium consumer market.
Bearish
- Severe Technical Downtrend: The stock is in a pronounced downtrend, down 12.23% over six months and 15.90% YTD, significantly underperforming the S&P 500. Trading at 81% of its 52-week range ($281.46 to $387.49), it shows persistent negative momentum with no clear reversal signal.
- Sequential Growth & Profit Deceleration: Revenue growth has decelerated from 16.8% in Q2 2025 to 9.5% in Q4 2025. Similarly, net income declined sequentially from $2.90 billion in Q3 to $2.46 billion in Q4, indicating potential margin pressure or increased credit provisioning.
- Elevated Valuation Multiples: Despite the recent sell-off, the trailing P/E of 23.73x and P/S of 3.20x are elevated for a financial services company. The PEG ratio of 2.43 suggests the stock is expensive relative to its expected earnings growth rate.
- Emerging Competitive Threat: Recent news highlights Robinhood's entry into the premium credit card market, directly targeting AXP's most profitable franchise. While not an immediate threat, this signals increasing competition for affluent customers from fintech disruptors.
AXP Technical Analysis
The stock is in a pronounced downtrend, having declined 12.23% over the past six months and 15.90% year-to-date, significantly underperforming the broader market. Currently trading at $313.48, it sits at approximately 81% of its 52-week range ($281.46 to $387.49), indicating it is much closer to its yearly lows than highs, which may signal a value opportunity but also reflects persistent negative momentum. Recent short-term momentum is weak and confirms the longer-term downtrend, with the stock down 4.73% over the past month and 7.12% over the past three months, showing no signs of a meaningful reversal. The stock's beta of 1.084 suggests its volatility is only slightly above the market, yet its deep underperformance, evidenced by a -20.54% relative strength over one year, points to significant company-specific or sector-specific headwinds. Key technical support is clearly defined at the 52-week low of $281.46, while resistance lies near the recent highs around $387.49; a sustained break below support could trigger a new leg down, while reclaiming the $340-$350 zone would be a first step toward stabilization.
Beta
1.08
1.08x market volatility
Max Drawdown
-24.1%
Largest decline past year
52-Week Range
$281-$387
Price range past year
Annual Return
+4.2%
Cumulative gain past year
| Period | AXP Return | S&P 500 |
|---|---|---|
| 1m | -5.9% | +4.0% |
| 3m | -9.4% | +8.2% |
| 6m | -9.4% | +11.5% |
| 1y | +4.2% | +24.3% |
| ytd | -16.2% | +8.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AXP Fundamental Analysis
Revenue growth remains healthy but shows signs of sequential deceleration; Q4 2025 revenue of $21.04 billion grew 9.5% year-over-year, yet this marks a slowdown from the 14.7% growth in Q3 2025 ($20.56 billion) and the 16.8% growth in Q2 2025 ($19.93 billion). The Global Consumer Services Group segment, at $9.16 billion for the latest period, is the largest revenue contributor, indicating the core consumer card business continues to be the primary growth driver. Profitability is strong with a net income of $2.46 billion in Q4 2025 and a robust gross margin of 83.49%, though net income declined sequentially from $2.90 billion in Q3 2025, reflecting potential margin pressure or increased provisioning. The company's net margin stands at 13.46%, and it maintains a high return on equity of 32.36%, underscoring its efficient use of shareholder capital. The balance sheet shows a debt-to-equity ratio of 1.73, which is elevated but manageable for a financial services firm, and it generates substantial cash flow with free cash flow (TTM) of $16.00 billion, providing ample liquidity for dividends, buybacks, and investments. However, the current ratio of 0.28 is very low, typical for a card network that does not hold significant short-term assets relative to its liabilities, but it highlights reliance on stable funding markets.
Quarterly Revenue
$21.0B
2025-12
Revenue YoY Growth
+0.09%
YoY Comparison
Gross Margin
+0.83%
Latest Quarter
Free Cash Flow
$16.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AXP Overvalued?
Given the positive net income, the primary valuation metric is the P/E ratio. The trailing P/E is 23.73x, while the forward P/E is significantly lower at 15.58x, indicating the market expects a substantial rebound in earnings growth over the next twelve months. Compared to sector averages (implied but not provided in data), the trailing P/E of 23.73x appears elevated for a financial services company, suggesting the market has historically priced in AXP's premium brand and growth profile. Historically, the stock's own trailing P/E has ranged widely; the current 23.73x is above the levels seen in 2023 (around 17-18x) but below the peak multiples above 25x seen in late 2025, indicating it is in the mid-to-upper range of its recent historical band, which may limit near-term multiple expansion potential. The price-to-sales ratio of 3.20x and EV/EBITDA of 17.16x provide additional context, confirming the stock trades at a premium to simple revenue multiples but a more moderate premium on cash flow.
PE
23.7x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 11x~26x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
17.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: AXP faces risks from its elevated debt-to-equity ratio of 1.73, which, while manageable, increases interest expense sensitivity in a rising rate environment. The sequential deceleration in revenue growth (from 16.8% to 9.5% over three quarters) and the Q4 net income decline from $2.90B to $2.46B signal potential margin pressure or rising credit costs, which could accelerate if the economy slows. The company's very low current ratio of 0.28 underscores a structural reliance on wholesale funding markets, making it vulnerable to liquidity crunches.
Market & Competitive Risks: The stock's valuation presents a key risk; its trailing P/E of 23.73x and P/S of 3.20x trade at a premium to typical financial services peers, leaving it exposed to multiple compression if growth continues to slow. The recent news of Robinhood launching a premium card is a tangible example of the emerging competitive threat from fintechs targeting AXP's core affluent customer base. Furthermore, the stock's beta of 1.084 and its severe underperformance (-20.54% relative strength over one year) indicate it is suffering from company-specific headwinds that may not abate quickly.
Worst-Case Scenario: The worst-case scenario involves a recessionary environment triggering a sharp rise in credit card charge-offs, combined with sustained competitive pressure from new entrants like Robinhood, leading to a simultaneous hit to revenues and profits. This could cause earnings to miss depressed forward estimates, triggering a derating of the forward P/E towards 12-13x. In this adverse scenario, the stock could realistically revisit its 52-week low of $281.46, representing a downside of approximately -10% from the current price of $313.48, with potential for further declines if sentiment sours dramatically.
FAQ
The key risks are, in order of severity: 1) Growth Deceleration Risk: Revenue growth has slowed from 16.8% to 9.5% in three quarters; a continuation threatens the premium valuation. 2) Credit & Economic Risk: As a lender, AXP is exposed to rising charge-offs in an economic downturn, which could sharply reduce net income. 3) Competitive Risk: New entrants like Robinhood are directly targeting its lucrative premium card segment. 4) Valuation Compression Risk: The elevated trailing multiples leave the stock vulnerable to derating if growth expectations are not met.
The 12-month forecast is a range of outcomes. The base case (55% probability) sees the stock trading between $320 and $350 as growth stabilizes and the forward P/E holds. The bull case (25% probability) could drive the stock to $370-$387 on earnings reacceleration and multiple expansion. The bear case (20% probability) risks a retest of the 52-week low near $281 if growth deteriorates further. The most likely scenario is the base case, which assumes the company navigates current headwinds without a major earnings miss, allowing the stock to recover from oversold levels.
AXP's valuation sends mixed signals. On a trailing basis, with a P/E of 23.73x and P/S of 3.20x, it appears overvalued compared to many financial peers. However, the forward P/E of 15.58x suggests the market expects a meaningful earnings rebound and offers a more reasonable entry point. The PEG ratio of 2.43 indicates the stock is expensive relative to its growth rate. Overall, it is fairly valued to slightly overvalued on current results but could be considered undervalued if the company meets its forward earnings estimates of ~$28.25 per share.
AXP is not an unequivocal good buy at this moment, but it presents a compelling risk/reward for patient investors. The forward P/E of 15.58x prices in significant pessimism, and the company's 32.36% ROE and $16 billion in TTM FCF are hallmarks of quality. However, with the stock in a clear downtrend and revenue growth decelerating, timing is poor. It is a good buy for long-term investors who believe in the durability of its premium brand and are willing to average in, but short-term traders should wait for a confirmed reversal in price momentum.
AXP is primarily suitable for a long-term investment horizon of 3+ years. Its business model and competitive moat are best appreciated over full economic cycles. The current volatility (beta 1.084) and lack of a near-term technical catalyst make it a poor short-term trading vehicle. The low dividend yield (0.88%) does not support an income strategy. Long-term investors can benefit from the company's high ROE and cash flow generation, but they must be prepared to endure significant drawdowns, as evidenced by the -24.06% max drawdown in the provided data.
